Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas

NICE clinical guidelines are recommendations about the treatment and care of people wit h specific diseases and conditions in the NHS in England and Wales. This guidance represents the view of NICE , which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account w hen exercising their clinical judgement. However, t he guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer , and informed by the summary of product characteristics of any drugs they are considering. Implementation of this guidance is the responsibility of local commissioners and/or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance, in their local context, in light of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. Nothing in this guidance should be interpreted in a way that would b e inconsistent with compliance with those duties.